Search Results Search Sort by RelevanceMost Recent Policy Forum Jul 2016 Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad Jing Luo, MD and Aaron S. Kesselheim, MD, JD, MPH The Trans-Pacific Partnership Agreement could affect low-income patients’ access to medicines in signatory countries by reducing generic competition. AMA J Ethics. 2016;18(7):727-735. doi: 10.1001/journalofethics.2016.18.7.pfor1-1607. Case and Commentary May 2019 Should Physicians Offer a Ventricular Assist Device to a Pediatric Oncology Patient With a Poor Prognosis? Angira Patel, MD, MPH, Anna Joong, MD, Efrat Lelkes, MD, and Jeffrey G. Gossett, MD When evaluating a 10-year-old with leukemia and chemo-induced heart failure for VAD placement, a team considers what to do. AMA J Ethics. 2019;21(5):E380-386. doi: 10.1001/amajethics.2019.380. Letter to the Editor Oct 2019 Response to “Emerging Roles of Virtual Patients in the Age of AI” Frederick W. Kron, MD, Timothy C. Guetterman, PhD, and Michael D. Fetters, MD, MPH, MA Selected ideas in C. Donald Combs and P. Ford Combs’ article, “Emerging Roles of Virtual Patients in the Age of AI,” are further considered. AMA J Ethics. 2019;21(10):E920-925. doi: 10.1001/amajethics.2019.920. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. Medical Education Feb 2019 Emerging Roles of Virtual Patients in the Age of AI C. Donald Combs, PhD and P. Ford Combs, MS Virtual reality technology’s promises and perils emerge when using VPs in health professions education. AMA J Ethics. 2019;21(2):E153-159. doi: 10.1001/amajethics.2019.153. Original Research Feb 2019 Can AI Help Reduce Disparities in General Medical and Mental Health Care? Irene Y. Chen, Peter Szolovits, PhD, and Marzyeh Ghassemi, PhD As machine learning becomes increasingly common in health care, these systems’ data, algorithms, and recommendations raise critical justice questions. AMA J Ethics. 2019;21(2):E167-179. doi: 10.1001/amajethics.2019.167. AMA Code Says Mar 2019 AMA Policies and Code of Medical Ethics’ Opinions Related to Health Promotion and Community Development Sienna Moriarty Physicians play important roles in community development when they seek to increase patients’ overall well-being through community engagement. AMA J Ethics. 2019;21(3):E259-261. doi: 10.1001/amajethics.2019.259. Medical Education May 2020 How Should Shared Decision Making Be Taught? Dong-Kha Tran, MD and Peter Angelos, MD, PhD There is great need for good teaching about how to have culturally appropriate conversations among clinicians, patients, and other stakeholders. AMA J Ethics. 2020;22(5):E388-394. doi: 10.1001/amajethics.2020.388. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Policy Forum Jul 2016 Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad Jing Luo, MD and Aaron S. Kesselheim, MD, JD, MPH The Trans-Pacific Partnership Agreement could affect low-income patients’ access to medicines in signatory countries by reducing generic competition. AMA J Ethics. 2016;18(7):727-735. doi: 10.1001/journalofethics.2016.18.7.pfor1-1607.
Case and Commentary May 2019 Should Physicians Offer a Ventricular Assist Device to a Pediatric Oncology Patient With a Poor Prognosis? Angira Patel, MD, MPH, Anna Joong, MD, Efrat Lelkes, MD, and Jeffrey G. Gossett, MD When evaluating a 10-year-old with leukemia and chemo-induced heart failure for VAD placement, a team considers what to do. AMA J Ethics. 2019;21(5):E380-386. doi: 10.1001/amajethics.2019.380.
Letter to the Editor Oct 2019 Response to “Emerging Roles of Virtual Patients in the Age of AI” Frederick W. Kron, MD, Timothy C. Guetterman, PhD, and Michael D. Fetters, MD, MPH, MA Selected ideas in C. Donald Combs and P. Ford Combs’ article, “Emerging Roles of Virtual Patients in the Age of AI,” are further considered. AMA J Ethics. 2019;21(10):E920-925. doi: 10.1001/amajethics.2019.920.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
Medical Education Feb 2019 Emerging Roles of Virtual Patients in the Age of AI C. Donald Combs, PhD and P. Ford Combs, MS Virtual reality technology’s promises and perils emerge when using VPs in health professions education. AMA J Ethics. 2019;21(2):E153-159. doi: 10.1001/amajethics.2019.153.
Original Research Feb 2019 Can AI Help Reduce Disparities in General Medical and Mental Health Care? Irene Y. Chen, Peter Szolovits, PhD, and Marzyeh Ghassemi, PhD As machine learning becomes increasingly common in health care, these systems’ data, algorithms, and recommendations raise critical justice questions. AMA J Ethics. 2019;21(2):E167-179. doi: 10.1001/amajethics.2019.167.
AMA Code Says Mar 2019 AMA Policies and Code of Medical Ethics’ Opinions Related to Health Promotion and Community Development Sienna Moriarty Physicians play important roles in community development when they seek to increase patients’ overall well-being through community engagement. AMA J Ethics. 2019;21(3):E259-261. doi: 10.1001/amajethics.2019.259.
Medical Education May 2020 How Should Shared Decision Making Be Taught? Dong-Kha Tran, MD and Peter Angelos, MD, PhD There is great need for good teaching about how to have culturally appropriate conversations among clinicians, patients, and other stakeholders. AMA J Ethics. 2020;22(5):E388-394. doi: 10.1001/amajethics.2020.388.